Michael Thomas Henderson

Director, Spyre Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$8.0M

Companies

Latest trade

Jun 22, 2026

Companies

Spyre Therapeutics, Inc.Director −$8.0M

Trades

SYRE Sold 20,000 shares at $100.00 · planned $2.0M Jun 22

SYRE Sold 80,000 shares at $74.40 · planned $6.0M May 8

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.